Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Bionic Implants Market Variables, Trends
  • Scope
      1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances
    
• 5.   Global Bionic Implants Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Bionic Implants Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Bionic Implants Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Hydroxychloroquine Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
  •   1. Vision Bionics
       1.1. Bionic Eye
      2. Ear Bionics
       2.1. Cochlear Implant
       2.2. Bone Anchored Hearing Aid
      3. Orthopedic Bionics
       3.1. Bionic Limb
       3.2. Bionic Hand
       3.3. Bionic Leg
        3.3.1. Bionic Knee
        3.3.2. Bionic Feet
       3.4. Bionic Finger
       3.5. Exoskeleton
       3.6. Electrical Bone Growth Stimulators
        3.6.1. Invasive Bone Growth Stimulators
        3.6.2. Non-Invasive Bone Growth Stimulators
      4.Heart Bionics
       4.1. Pacemaker
        4.1.1. Implantable Cardiac Pacemaker
        4.1.2. External Pacemaker
       4.2. Total Artificial Heart
       4.3. Ventricular Assist Device
       4.4. Artificial Heart Valves
        4.4.1. Mechanical Heart Valves
        4.4.2. Tissue Heart Valves
      5. Neural /Brain Bionics
       5.1. Deep Brain Stimulator
       5.2. Vagus Nerve Stimulator
       5.3. Spinal Cord Stimulator
    
• 8.   Hydroxychloroquine Market, By Method of Fixation Historical Analysis and Forecast 2022-2028 (USD Million)
  •   1. Implantable
      2. Externally Worn
    
• 9.   Hydroxychloroquine Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
  •   1. Mechanical
      2. Electronic
    
• 10.   North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2022-2028
    
• 11.   Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  •   1. Introduction
      2. Regional Market Trends
      3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       3.1. Brazil
       3.2. Venezuela
       3.3. Argentina
       3.4. Rest of Latin America
      4. Market Size (USD Million) Forecast for Latin America 2022-2028
    
• 12.   Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       2.1. Germany
        2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Switzerland
       2.9. Rest of Western Europe
      3. Market Size (USD Million) Forecast for Europe 2022-2028
    
• 13.   Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       2.1. Japan
       2.2. China
       2.3. Singapore
       2.4. India
       2.5. Australia and New Zealand
       2.6. ASEAN
       2.7. South Korea
       2.8. Taiwan
       2.9. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
    
• 14.   Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2022-2028
    
• 15.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
  •     1. Orthofix International N.V.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
       2. Biomet, Inc.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Roche Holding AG
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Medtronic, Inc
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
       16.5 . Cochlear, Ltd.
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
       16.6 . Second Sight Medical Products, Inc.
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Ossur
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Ekso Bionics
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
        16.9 . St. Jide Medical, Inc.
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
    
• 17.   Pre and Post COVID-19 Impact
  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
    
• 18.   FutureWise SME Key Takeaway Points for Client